Wells Fargo Portfolio holdings
Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$799M |
| 2 |
Tesla
TSLA
|
+$295M |
| 3 |
PPG Industries
PPG
|
+$256M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$256M |
| 5 |
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.11B |
| 2 |
Amazon
AMZN
|
+$1.93B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.47B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 5 |
Apple
AAPL
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.3% |
| 2 | Healthcare | 8.05% |
| 3 | Financials | 7.53% |
| 4 | Consumer Discretionary | 6.73% |
| 5 | Industrials | 6.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5376
Outlook Therapeutics
OTLK
$215M
| $107K | ﹤0.01% |
3,908
+3,556
| +1,010% | +$127K |
|
|
PNI
5377
PIMCO New York Municipal Income Fund II
PNI
$78M
| $107K | ﹤0.01% |
9,472
+1,923
| +25% | +$22K |
|
5378
Procept Biorobotics
PRCT
$1.24B
| $107K | ﹤0.01% |
+4,289
| New | +$159K |
|
5379
Pacer Trendpilot US Bond ETF
PTBD
$86.1M
| $107K | ﹤0.01% |
3,967
+3,587
| +944% | +$96.6K |
|
5380
WisdomTree Japan SmallCap Dividend Fund
DFJ
$396M
| $106K | ﹤0.01% |
1,488
-212
| -12% | -$15.5K |
|
5381
Global X MSCI Norway ETF
NORW
$87M
| $106K | ﹤0.01% |
3,478
+3,110
| +845% | +$96.7K |
|
|
IMDX
5382
Insight Molecular Diagnostics
IMDX
$154M
| $106K | ﹤0.01% |
2,440
-1,315
| -35% | -$75.6K |
|
5383
Neuronetics
STIM
$151M
| $106K | ﹤0.01% |
23,899
-189,437
| -89% | -$928K |
|
5384
CALL
TJX Companies
TJX
$175B
| $106K | ﹤0.01% |
1,400
-62,400
| -98% | -$4.33M |
|
|
CASA
5385
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $106K | ﹤0.01% |
18,619
+11,103
| +148% | +$64.3K |
|
5386
Atossa Therapeutics
ATOS
$23.7M
| $105K | ﹤0.01% |
+4,377
| New | +$160K |
|
5387
Immunovant
IMVT
$8.24B
| $105K | ﹤0.01% |
12,423
+12,370
| +23,340% | +$102K |
|
5388
National CineMedia
NCMI
$370M
| $105K | ﹤0.01% |
3,736
-8,427
| -69% | -$268K |
|
5389
Passage Bio
PASG
$13.9M
| $105K | ﹤0.01% |
823
+792
| +2,555% | +$129K |
|
5390
INNOVATE Corp
VATE
$97.3M
| $105K | ﹤0.01% |
2,834
+1,898
| +203% | +$75.4K |
|
|
CBAY
5391
DELISTED
Cymabay Therapeutics
CBAY
| $105K | ﹤0.01% |
30,981
+26,784
| +638% | +$102K |
|
|
CFVIU
5392
DELISTED
CF Acquisition Corp. VI Unit
CFVIU
| $105K | ﹤0.01% |
9,200
-21,352
| -70% | -$234K |
|
5393
Carlyle Secured Lending
CGBD
$766M
| $104K | ﹤0.01% |
7,590
+2,617
| +53% | +$36.2K |
|
5394
CorMedix
CRMD
$591M
| $104K | ﹤0.01% |
22,691
+21,970
| +3,047% | +$109K |
|
5395
LiveOne
LVO
$60.4M
| $104K | ﹤0.01% |
8,129
+4,034
| +99% | +$88.4K |
|
|
TGB
5396
Trekor Metals
TGB
$3.21B
| $104K | ﹤0.01% |
+51,076
| New | +$107K |
|
|
TCRR
5397
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $104K | ﹤0.01% |
22,291
+74
| +0.3% | +$463 |
|
5398
Ardelyx
ARDX
$997M
| $103K | ﹤0.01% |
93,591
-18,638
| -17% | -$22.1K |
|
5399
Citius Pharmaceuticals
CTXR
$18.6M
| $103K | ﹤0.01% |
2,686
-23,258
| -90% | -$1.06M |
|
5400
DarioHealth
DRIO
$74.7M
| $103K | ﹤0.01% |
400
+375
| +1,500% | +$114K |
|
Similar funds
Wells Fargo's Q4 2021 Portfolio in Review
As of Q4 2021, Wells Fargo held 8,381 positions worth $401B, down 12% from $455B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Wells Fargo withdrew a net $88.2B in Q4 2021, closing 389 positions and reducing 3,415 holdings. Its most notable exit was Kansas City Southern, an estimated $61.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Wells Fargo opened a new position in Bank of America Series L worth $44.7M.
- Wells Fargo's largest Q4 2021 buy was Bank of America Series L: 30,939 shares worth $44.7M.
- Wells Fargo added most to Vanguard Morningstar Mid-Cap ETF in Q4 2021, an estimated $799M increase.
- Wells Fargo's biggest Q4 2021 reduction was Microsoft, cutting an estimated $3.11B.
- Wells Fargo fully exited Kansas City Southern in Q4 2021, selling an estimated $61.9M.
- Wells Fargo's ten largest holdings make up 18% of its $401B portfolio in Q4 2021.
- Wells Fargo opened 685 new positions and closed 389 in Q4 2021.
- Wells Fargo's portfolio value fell 12% quarter-over-quarter to $401B.
Based on Wells Fargo's 13F filing for Q4 2021, filed 14 Feb 2022.